Search results
Results from the Tech24 Deals Content Network
For premium support please call: 800-290-4726 more ways to reach us
(Reuters) -Shares of Geron surged more than 20% on Friday, a day after the company gained its first approval from the U.S. Food and Drug Administration for its blood disorder drug. The health ...
(Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday backed benefits of Geron's blood disorder drug, saying it outweighed the risks associated with the treatment, based on data ...
Geron, based in Foster City, California, was founded by gerontologist Mary C. West and Michael D. West, now CEO of AgeX Therapeutics. [2] [3] They secured initial venture capital investments in the company from Kleiner Perkins Caufield & Byers and Venrock. [4] The company was incorporated in 1990 and began doing business in 1992.
With 2012 just beginning, now's a great time to gauge how the stocks you're interested in are likely to do this year and beyond. By knowing what stock analysts and fellow investors expect from a ...
For premium support please call: 800-290-4726 more ways to reach us
Geron (GERN) telomerase inhibitor, imetelstat, is being evaluated in two late stage studies for patients with MDS and myelofibrosis. The candidate is progressing well in Janssen sponsored studies.
The mean of analysts' price targets for Aemetis (AMTX) points to a 210% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among ...